Sign in
  • Home
  • News Bytes
  • Lead Story
  • Editor’s Zone
  • Industry Reports
  • Events
  • Expert Column
  • Policy
  • Startup Tracker
  • Face to Face
  • Chat with BioVoice
  • BioVoice eMag
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Friday, April 17, 2026
  • Subscribe
  • SUBSCRIBE
  • Write to Us
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
BioVoice BioVoiceNews
wellness India Expo
BioVoice BioVoice
  • Home
  • News Bytes
    • Academia

      Biocon Foundation, in partnership with BeST Cluster and NCBS, onboards first…

      Biotech

      Bayer to offer Eylea 2mg to treat retinal diseases at lower…

      Biosupplier

      Agilent launches a new customer experience center in Mumbai

      Health

      Cardiology experts emphasize early diagnosis amid rising incidence of Bradycardia

      Health

      4baseCare signs MoU with Maharashtra govt to establish Centre of Excellence…

  • Lead Story
    • BioPharma

      Emcure Pharma reduces Poviztra® starting dose price by 55% at Rs…

      Biotech

      India’s bioeconomy set to hit $300B as patent cliff fuels innovation…

      BioPharma

      Biologics, mRNA and Bio Foundries to set the course for pharma’s…

      Diagnostics

      Yoda Diagnostics hosts ‘Yoda Early Mind Summit’ in New Delhi

      Biovoice Shreehas Tambe
      People

      Shreehas Tambe appointed CEO & MD of Biocon Limited, effective April…

  • Editor’s Zone
    • Health Policy

      A Silent Victory: How Uttar Pradesh reversed its Encephalitis crisis

      Policy

      Beyond Trade: How the EU–India FTA reshapes life-sciences industry

      Editor’s Zone

      Safeguarding Our Healers – India’s Doctors Need Protection

      Editor’s Zone

      Lost in Translation? India’s Biologics R&D Shortfall

      Editor’s Zone

      Bridging Science and Business: The Missing Link in Bioscience Innovation

  • Industry Reports
    • Industry Reports

      India Biotech Outlook 2025: The India Advantage at BIO Boston 2025

      Industry Reports

      Inviting your participation in the upcoming India MedTech Handbook 2024

      Industry Reports

      BioVoice News & ICPA team presents India MedTech Handbook 2023 to…

      MedTech

      India MedTech Handbook 2023 launched at the MedTech Conference in USA

      MedTech

      Releasing Soon: India MedTech Handbook 2023 powered by ICPA & BioVoice…

  • Events
    • video
      Events

      Digitalization has democratized healthcare: Experts at BioVoice News e-Conference

      Events

      BioVoice News to host e-Conference on India’s roadmap to Digital Healthcare…

      video
      Events

      Digitally powered smart labs are the future of biopharma R&D: Experts

      Events

      BioVoice News to organize e-Conference on ‘Digital Laboratories: The Emerging Era…

  • Expert Column
    • Expert Column

      Reimagining preventive medicine through genomics, AI, and early risk detection

      Expert Column

      Early cancer detection begins with getting the first step right

      Expert Column

      Leveraging AI to Strengthen India’s Healthcare System

      Expert Column

      The Rise of HealthTech Startups: Innovations Shaping the Future of Medicine

      Expert Column

      How India is Countering the Growing Challenge of Drug-Resistant TB

  • Policy
    • Health Policy

      TB survivors seek govt clarification on continuity of TB medicines &…

      Events

      BioAsia 2026 positions Telangana as a global TechBio powerhouse

      AgriPolicy

      Budget 2026 charts a technology-led path for Indian agriculture

      Health

      Budget 2026: Healthcare skill development & medical tourism gets due attention

      BioPolicy

      Telangana sets global ambition with next generation life sciences policy 2026–30

  • Startup Tracker
    • Startup Tracker

      IIIT Hyderabad incubated biotech startup BioReform bags global award for ditching…

      Startup Tracker

      Gut Clinic raises $1 million in seed round to build India’s…

      Startup Tracker

      IAN Alpha Fund co-leads ₹70 Cr Series A funding round in…

      Biovoice News invests
      Startup Tracker

      Pandorum Technologies raises US$18 Million in Series B to advance global…

      Startup Tracker

      4baseCare raises Rs 90 Cr in Series B first close led…

  • Face to Face
    • Face to Face

      “Research must be designed for translation, not just for publications”: Dr…

      video
      Face to Face

      Face to Face with BioVoice News: Dr Sajeev Nair, Founder &…

      video
      Face to Face

      FACE TO FACE: Dr Taslimarif Saiyed, Director and CEO, Centre for Cellular…

      video
      Face to Face

      FACE TO FACE: Harish Bisam, Founder & MD, Bisam Pharmaceuticals

      video
      Face to Face

      FACE TO FACE: Dr Pawan Dhar, Executive Director, CVJ Centre for…

  • Chat with BioVoice
    • Chat with BioVoice

      “Biologics and biosimilars represent Veeda’s second-highest strategic priority after clinical trials”

      Chat with BioVoice

      “AI’s biggest contribution in cardiac monitoring is its speed and efficiency”

      Chat with BioVoice

      “Our focus is on identifying biological mechanisms that may offer alternative…

      Chat with BioVoice

      “We plan to invest Rs 50 crore in phase for R&D…

      Chat with BioVoice

      “Merck has made significant efforts to strengthen lab solutions and R&D…

  • BioVoice eMag
    • BioVoice eMag

      BioVoice eMagazine November 2025 | Issue 10 | Volume 6

      BioVoice eMag

      BioVoice eMagazine October 2025 | Issue 9 | Volume 6

      BioVoice eMag

      BioVoice eMagazine September 2025 | Issue 8 | Volume 6

      BioVoice eMag

      BioVoice eMagazine July-August 2025 | Issue 7 | Volume 6

      BioVoice eMag

      BioVoice eMagazine June 2025 | Issue 6 | Volume 6

Home Health NHA revamps ABHA mobile application to manage health records under Ayushman Bharat...
  • Health
  • Health Policy
  • News Bytes
  • Policy
  • Top News

NHA revamps ABHA mobile application to manage health records under Ayushman Bharat Digital Mission

The revamped Ayushman Bharat Health Account (ABHA) mobile application offers added functionalities and a new User Interface (UI) for improved usability

By BioVoice News Desk -
May 24, 2022
0
279
Share on Facebook
Tweet on Twitter
New Delhi: The National Health Authority (NHA) under its flagship scheme of Ayushman Bharat Digital Mission (ABDM) announced the launch of a revamped Ayushman Bharat Health Account (ABHA) mobile application.
The ABHA app, previously known as NDHM Health Records app is available for download from the Google Play Store and already has over 4 lakh downloads. The updated version of the ABHA app has new User Interface (UI) and added functionalities that enable individuals to access their health records anytime and anywhere. Existing ABHA app users can also update their previous app versions to the latest one.
The ABHA mobile application enables an individual to create an ABHA address (username@abdm), an easy to remember username that can be linked with the 14 digit randomly generated ABHA number. The mobile application also enables users to link their health records created at ABDM compliant health facility and view them in their smartphones. The application also allows self-uploading of physical health records in the ABDM compliant health lockers along with sharing of digital health records such as diagnostic reports, prescriptions, CoWIN vaccination certificate etc. after the consent of an individual through the ABDM network.
In addition to this, ABHA mobile application has new functionalities such as edit profile, link and unlink ABHA number (14 digit) with ABHA address. Other functionalities such as Login via face authentication / fingerprint/ biometric and ability to scan QR code at the counter of the ABDM compliant facility for express registration shall also be released soon.
Elaborating on the ABHA mobile app, Dr. R.S. Sharma, CEO, National Health Authority (NHA) said: “The ABHA app will be instrumental in helping citizens to create their longitudinal health records. The patients can access their health records with the help of their ABHA address in seconds which will empower them in many ways. It will enable them to save their health history on a single platform and access or share their health records anytime and anywhere without a worry of losing them. This digitization of data exchange will ensure better clinical decision making and continuum of care.”
The Ayushman Bharat Health Account (ABHA) Mobile App (previously known as NDHM Health Records or PHR App) can be downloaded from the Google Play Store or by clicking. The iOS version of the ABHA mobile app will be launched shortly.

VIABioVoice New Delhi Bureau
  • TAGS
  • Authority
  • Ayushman Bharat Health Account
  • Health
  • India
  • Mobile
  • National
  • NDHM
  • NHA
Previous articleKarkinos Healthcare receives investment for development of innovative healthcare solutions
Next articleIntegrating mental health into primary healthcare in India: Challenges & Way forward
BioVoice News Desk

RELATED ARTICLESMORE FROM AUTHOR

Academia

Biocon Foundation, in partnership with BeST Cluster and NCBS, onboards first BioWISE cohort of Postgraduate Women Students

Biotech

Bayer to offer Eylea 2mg to treat retinal diseases at lower cost in India

Biosupplier

Agilent launches a new customer experience center in Mumbai

Face to Face

Face to Face

“Research must be designed for translation, not just for publications”: Dr...

Rahul Koul - December 18, 2025
313
Dr Sagar Sengupta, Director, National Institute of Biomedical Genomics (NIBMG) and Director (Additional Charge), National Brain Research Centre (NBRC) shared his insights on the latest initiatives, importance of industry-academia collaboration, increased government funding, and evolution of research ecosystem

e-Conference

https://www.youtube.com/watch?v=Nku-bLFGpBI&t=491s

Subscribe Our Newsletter


Chat with BioVoice

Chat with BioVoice

“Biologics and biosimilars represent Veeda’s second-highest strategic priority after clinical trials”

Rahul Koul - February 26, 2026
148
Binoy Gardi, Managing Director and Group CEO, Veeda Lifesciences shared insights on his latest role and top priorities; the company's latest initiatives, outcomes of key acquisitions and future plans

“AI’s biggest contribution in cardiac monitoring is its speed and efficiency”

January 28, 2026

“Our focus is on identifying biological mechanisms that may offer alternative...

January 19, 2026

R&D

BioPolicy

DBT & BIRAC host webinar on biomanufacturing & biofoundry initiative on...

R&D

New magnetic nanoparticles may help treat cancer

Events

Industry Reports

India Biotech Outlook 2025: The India Advantage at BIO Boston 2025

Events

BioAsia 2025: C4IR Telangana & WEF to spearhead high-level dialogues on...

Events

Countdown begins to BioAsia 2025: A unique platform to showcase startup...

AgriPolicy

NDFC(I) inaugurates 2nd edition of MEWA India 2025

BioVoice
ABOUT US
Welcome to BioVoice News, India’s leading bioscience B2B media network. It serves as credible go-to source for the latest news, insights, interviews and analysis from the dynamic worlds of BioTech, HealthTech and AgriTech. Read More
Contact us: connect@biovoicenews.com
FOLLOW US
  • Terms of Use
  • Privacy
  • Advertise
  • Contact
© Copyright © 2022-2025 BioVoiceNews.com All rights reserved.